Sort   by:  
 Page size 
UnknownNext-Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development.
Not available
S-EPMC7006882 | biostudies-literature
UnknownOverview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials.
Not available
S-EPMC8184702 | biostudies-literature
UnknownA pilot study using hospital surveillance and a birth cohort to investigate enteric pathogens and malnutrition in children, Dili, Timor-Leste.
Not available
S-EPMC10833528 | biostudies-literature
TranscriptomicsCharacteristic molecular and proteomic signatures of drug-induced liver injury in a rat model
we assessed characteristic molecular and proteomic signatures in rat liver treated with drugs (pyrazinamide, ranitidine, enalapril, carbamazepine, and chlorpromazine) that are known to cause DILI in humans. In the present study, we assessed the characteristic gene expression signature for DILI in a ...
ORGANISM(S): Rattus norvegicus 
2013-08-16 | E-GEOD-49631 | biostudies-arrayexpress
UnknownEvaluation of DILI Predictive Hypotheses in Early Drug Development.
Not available
S-EPMC5674994 | biostudies-literature
UnknownThe Promise of AI for DILI Prediction.
Not available
S-EPMC8080874 | biostudies-literature
UnknownBiomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review.
Not available
S-EPMC7617394 | biostudies-literature
UnknownQuantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition.
Not available
S-EPMC4362924 | biostudies-literature
UnknownA revised electronic version of RUCAM for the diagnosis of DILI.
Not available
S-EPMC9233102 | biostudies-literature
UnknownThe Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment.
Not available
S-EPMC9227129 | biostudies-literature
Sort   by:  
 Page size